Sonire Therapeutics raises $18m for tumour ablation platform advancement
Sonire Therapeutics has raised $18m towards supporting the ongoing clinical advancement of its non-invasive thermal ablation tumour treatment system. The Tokyo, …
Sonire Therapeutics has raised $18m towards supporting the ongoing clinical advancement of its non-invasive thermal ablation tumour treatment system. The Tokyo, …
Calyxo has raised $40m in a financing round; at the same time, the company has achieved a milestone of 40,000 …
Protaryx Medical has received the US Food and Drug Administration (FDA) 510(k) clearance to market its proprietary transseptal puncture device. The …
US-based Avanos Medical has entered a definitive agreement to be acquired by affiliates of American Industrial Partners (AIP) in an …
Boston Scientific has shared efficacy data for its Farapulse pulsed-field ablation (PFA), recording 65% efficacy for the system at one …
ProSomnus Sleep Technologies has received the US Food and Drug Administration (FDA) Class II 510(k) clearance for its RPMO₂ OSA …
Heartflow has filed a lawsuit against Cleerly, alleging that three of the Texas-based company’s artificial intelligence (AI)-based tools for coronary …
Johnson & Johnson (J&J) has reported interim 12-month results from the VARIPURE study, assessing the effectiveness and safety of its …
Stryker has agreed to acquire Amplitude Vascular Systems (AVS) in a move to broaden the medtech giant’s vascular care portfolio …
Beckman Coulter Diagnostics has obtained a European CE mark for the use of its laboratory test designed to distinguish between …
Roche has received CE mark approval of its Elecsys neurofilament light chain (NfL) test, which is designed to detect neuroinflammation …
Zebra Technologies and Aiva Health have collaborated to support hands-free nurse workflows with Aiva's AI-powered solution. This partnership integrates Aiva’s AI-based …
Sunrise Group’s Dreem Health, a virtual sleep clinic for the treatment and evaluation of conditions such as sleep apnoea, has …
Boehringer Ingelheim and Click Therapeutics have shifted the dynamic of their long-term collaboration, which will see Click take the commercialisation …
The US Food and Drug Administration (FDA) has cleared Waters Corporation’s Onclarity human papillomavirus (HPV) self-collection kit in a development …